Morgan Stanley: Strong China Fab Equipment Demand, 23% Growth Each in 2027-2028
nashnova research
Morgan Stanley projects China's wafer fabrication equipment (WFE) spending will rise from $45.6 billion in 2026 to $68.6 billion in 2028, with 23% year-on-year growth in each of the last two years — as the growth engine shifts from mature-node expansion to memory and advanced process.
Where does the money go — and how is the growth engine shifting?
Morgan Stanley forecasts China WFE spending at $45.6B, $55.8B, and $68.6B for 2026/2027/2028, accounting for roughly 28%, 25%, and 27% of global WFE.
This means → China's equipment market is not just large — it is accelerating, with two consecutive years of 23% growth above the global average.
The growth driver is rotating: memory expansion leads in 2027; advanced-node logic chips take over in 2028, sustaining demand for etch, deposition, and cleaning tools.
In plain terms = the first two years are fueled by "build more memory fabs"; the third year by "make more advanced chips" — spending stays elevated throughout.
Are CXMT and YMTC expansion plans on track?
CXMT (Chang Xin Memory Technologies): Morgan Stanley expects 100K wafers-per-month of new capacity added each year from 2026 to 2028, lifting total DRAM capacity from 180K wpm in 2025 to 500K wpm by 2028.
Supply-chain checks suggest CXMT's planned Lingang expansion may be delayed, with more capacity shifting to Hefei. This means → a change in location and timing, not in the medium-term volume target.
YMTC (Yangtze Memory Technologies) has completed IPO coaching and is pursuing an A-share listing, targeting RMB 33 billion in proceeds — of which RMB 20.8 billion goes to production-line upgrades. This reflects a locked-in funding source for continued equipment purchases.
YMTC's projected new capacity: 35K, 100K, and 100K wpm for 2026, 2027, and 2028 respectively.
How could the MATCH Act affect China's fabs?
The bipartisan MATCH Act — a bill that would coordinate allied export controls on critical semiconductor equipment such as deep-ultraviolet immersion lithography tools — would restrict equipment sales, maintenance, and technical support to CXMT, YMTC, SMIC, Hua Hong, and other Chinese fabs.
Morgan Stanley believes the market has not fully priced in the potential impact of tighter multilateral controls on capacity-ramp timelines.
In plain terms = even if a fab is built, it may face delayed production because key tools become unavailable — and that risk is largely absent from current valuations.
Could tighter restrictions actually accelerate domestic substitution?
China's WFE localization rate is expected to be only about 25% in 2026.
This means → three-quarters of equipment still comes from abroad — any tightening opens a wide opportunity window for domestic suppliers.
Stricter controls could speed up the qualification of domestic etch, deposition, and cleaning tools, helping local firms capture share faster.
In plain terms = the short-term hit lands on fab construction, but the medium-term catalyst goes to domestic equipment makers — "chokepoint" pressure forces substitution orders.
What is the call on Naura, AMEC, and ACMR?
Morgan Stanley maintains Overweight ratings on all three but trims price targets due to higher R&D expense assumptions.
Naura Technology (北方华创): target cut from RMB 818 to RMB 788; Q2 2026 parts-procurement restrictions caused delivery delays. Naura spans deposition, etch, and thermal processing — still Morgan Stanley's top pick as a broad beneficiary.
ACMR (ACM Research): target cut from $130 to $115; higher R&D costs from new PECVD — plasma-enhanced chemical vapor deposition, a process that deposits thin films on chip surfaces — and track/coater platforms. Morgan Stanley remains positive on ACMR's memory demand exposure and non-cleaning equipment pipeline.
AMEC (中微公司): target cut from RMB 488 to RMB 428, mainly due to a share split. But benefiting from stronger memory-fab expansion, 2027-2028 revenue estimates are each raised 12%.
What would confirm — or break — this forecast?
Morgan Stanley flags two core variables: legislative progress of the MATCH Act and the actual capacity-ramp pace at CXMT and YMTC.
This means → if the bill advances faster or capacity ramps slower than expected, the growth numbers above could face meaningful downside.
In plain terms = the "certainty" of equipment demand rests on two tracks — policy and capacity. A surprise on either one forces a forecast revision.
市场有风险，内容仅供研究参考，不构成投资建议。